Stroke Trial, Recruiting NCT05832567 Sponsor: Spaulding Rehabilitation Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05832567
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults (aged 18 or older) who have weakness or limited movement on one side of the body as a result of a stroke.
  • The stroke must have occurred at least 6 months ago.
  • Scores on a specific arm movement test called the Fugl-Meyer Upper Extremity scale must fall within a particular range (above 11 and up to 56), indicating a moderate level of arm impairment (confirm with trial site).
  • People who had little to no disability before their stroke, based on a standard disability rating scale (a score below 3 on the Modified Rankin Scale).

Who may not be able to join:

  • People whose stroke affected a specific area of the brain (the front part, called the anterior cerebral artery territory) and who also show certain changes in brain activity in that area (confirm with trial site).
  • People who are unable to understand and follow instructions.
  • People who have certain implanted medical devices near the head, such as a cochlear implant (a hearing device), an internal pulse generator, or a medical pump, as these may interfere with the brain stimulation treatment used in the trial.
  • People with other serious or unstable health conditions at the time of joining.
  • People with significant depression symptoms, based on a score of 24 or higher on a standard depression rating scale (the Hamilton Depression Rating Scale).
  • People experiencing joint pain or pain in the affected arm or hand that is likely to interfere with assessments.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Felipe Fregni, MD, PhD, MPH, Spaulding Rehabilitation Hospital/Harvard Medical School

Phone: 6179526156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Spaulding Rehabilitation Hospital
Registry
ClinicalTrials.gov
Start date
11 September 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Electroencephalography (EEG): Frontal alpha asymmetry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov